TrialBritish journal of clinical pharmacology2018

Urinalysis of MMX-mesalazine as a tool to monitor 5-ASA adherence in daily IBD practice.

Tessa E H Römkens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.